Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 GlobeNewswire
||
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the... Matador Technologies Inc. Announces Market Making Partnership with Independent Trading GroupMatador Technologies Inc. Announces Market Making Partnership with Independent Trading Group GlobeNewswire
||
TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) — Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA) announces that it has entered into a Market Making Services Agreement with Independent... 
GlobalFoundries Announces Conference Call to Review Fourth Quarter and Full-Year 2024 Financial ResultsGlobalFoundries Announces Conference Call to Review Fourth Quarter and Full-Year 2024 Financial Results GlobeNewswire
||
MALTA, N.Y., Jan. 08, 2025 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Tuesday, February 11, 2025, at 8:30 a.m. ET... 
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical TrialSilo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial GlobeNewswire
||
SARASOTA, FL, Jan. 08, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug... 
DatChat, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced At-The Market Under Nasdaq RulesDatChat, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules GlobeNewswire
||
New Brunswick, NJ, Jan. 08, 2025 (GLOBE NEWSWIRE) — DatChat, Inc. (Nasdaq: DATS) (“DatChat” or the “Company”), a secure messaging, social media, and metaverse company, today announced that it... 
Trace One and Syscons Partner to Enhance Product Development in the Consumer Goods and Retail SectorsTrace One and Syscons Partner to Enhance Product Development in the Consumer Goods and Retail Sectors GlobeNewswire
||
PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) — Trace One, a leading provider of Product Lifecycle Management (PLM) solutions, has announced a strategic partnership with Syscons, a system integration boutique... 
Moonacy Protocol Paid Out Over $3.5 Million to Investors for December 2024Moonacy Protocol Paid Out Over $3.5 Million to Investors for December 2024 GlobeNewswire
||
London, UK, Jan. 08, 2025 (GLOBE NEWSWIRE) — Moonacy Protocol continued its impressive growth in December 2024, paying out over $3.5 million dollars to its investors. This significant achievement underscores... 
Wearable Devices and RayNeo to Unveil Transformative Gesture-Controlled AR Glasses Powered by Mudra Neural Wristband and Snapdragon XR Platform at CES®Wearable Devices and RayNeo to Unveil Transformative Gesture-Controlled AR Glasses Powered by Mudra Neural Wristband and Snapdragon XR Platform at CES® GlobeNewswire
||
Yokneam Illit, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) and RayNeo™ today announced their groundbreaking collaboration to redefine the augmented reality (“AR”) experience... 
AITX’s RAD-R Welcomes Steve Danelon as President, Strengthening Leadership for Residential Security SolutionsAITX’s RAD-R Welcomes Steve Danelon as President, Strengthening Leadership for Residential Security Solutions GlobeNewswire
||
Danelon Brings Two Decades of Leadership and Operational Expertise to Drive RAD-R’s Residential Security Expansion Detroit, Michigan, Jan. 08, 2025 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the... 
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming MilestonesSensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones GlobeNewswire
||
– Solnerstotug (SNS-101) dose expansion arm anticipated to be fully enrolled by end of Q1 2025 – – Clinical data update expected in Q2 2025 – BOSTON, Jan. 08,...